Overview
Phase I 2-Way Crossover Study to Assess Relative BA of Tablet Versus Liquid Suspension and Food Effect on Tablet Formulation
Status:
Completed
Completed
Trial end date:
2009-04-01
2009-04-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to compare the liquid suspension form of AZD 2624 to a tablet form of the same drug. This study will also study the effect of food on the tablet form of the drug.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
AstraZeneca
Criteria
Inclusion Criteria:- Healthy male and female volunteers
Exclusion Criteria:
- Donation of plasma or blood products within one month of of screening
- Clinically relevant abnormalities in physical examination, vital signs,ECG, clinical
chemistry, hematology, or urinalysis.
- Previous participation in an AD2624 study.